These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24272681)

  • 1. A marginal structural model for multiple-outcome survival data:assessing the impact of injection drug use on several causes of death in the Canadian Co-infection Cohort.
    Moodie EE; Stephens DA; Klein MB
    Stat Med; 2014 Apr; 33(8):1409-25. PubMed ID: 24272681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correcting for Measurement Error in Time-Varying Covariates in Marginal Structural Models.
    Kyle RP; Moodie EE; Klein MB; Abrahamowicz M
    Am J Epidemiol; 2016 Aug; 184(3):249-58. PubMed ID: 27416840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On Bayesian estimation of marginal structural models.
    Saarela O; Stephens DA; Moodie EE; Klein MB
    Biometrics; 2015 Jun; 71(2):279-88. PubMed ID: 25677103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the impact of hepatitis C viral clearance on end-stage liver disease in an HIV co-infected cohort with targeted maximum likelihood estimation.
    Schnitzer ME; Moodie EE; van der Laan MJ; Platt RW; Klein MB
    Biometrics; 2014 Mar; 70(1):144-52. PubMed ID: 24571372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missing data in the exposure of interest and marginal structural models: a simulation study based on the Framingham Heart Study.
    Shortreed SM; Forbes AB
    Stat Med; 2010 Feb; 29(4):431-43. PubMed ID: 20025082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulating from marginal structural models with time-dependent confounding.
    Havercroft WG; Didelez V
    Stat Med; 2012 Dec; 31(30):4190-206. PubMed ID: 22826156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
    Geskus RB
    Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of liver disease mortality with HIV and overdose mortality among Georgia prisoners and releasees: a 2-decade cohort study of prisoners incarcerated in 1991.
    Spaulding AC; Sharma A; Messina LC; Zlotorzynska M; Miller L; Binswanger IA
    Am J Public Health; 2015 May; 105(5):e51-7. PubMed ID: 25790417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.
    Hernán MA; Brumback BA; Robins JM
    Stat Med; 2002 Jun; 21(12):1689-709. PubMed ID: 12111906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of longitudinal marginal structural models.
    Bryan J; Yu Z; Van Der Laan MJ
    Biostatistics; 2004 Jul; 5(3):361-80. PubMed ID: 15208200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A test for the correct specification of marginal structural models.
    Sall A; Aubé K; Trudel X; Brisson C; Talbot D
    Stat Med; 2019 Jul; 38(17):3168-3183. PubMed ID: 30856294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrumental variable estimation of the causal hazard ratio.
    Wang L; Tchetgen Tchetgen E; Martinussen T; Vansteelandt S
    Biometrics; 2023 Jun; 79(2):539-550. PubMed ID: 36377509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling time-varying exposure using inverse probability of treatment weights.
    Grafféo N; Latouche A; Geskus RB; Chevret S
    Biom J; 2018 Mar; 60(2):323-332. PubMed ID: 29280181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural equation modeling versus marginal structural modeling for assessing mediation in the presence of posttreatment confounding.
    Moerkerke B; Loeys T; Vansteelandt S
    Psychol Methods; 2015 Jun; 20(2):204-20. PubMed ID: 25751514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.
    Brumback BA; Hernán MA; Haneuse SJ; Robins JM
    Stat Med; 2004 Mar; 23(5):749-67. PubMed ID: 14981673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted learning in real-world comparative effectiveness research with time-varying interventions.
    Neugebauer R; Schmittdiel JA; van der Laan MJ
    Stat Med; 2014 Jun; 33(14):2480-520. PubMed ID: 24535915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the marginal structural models under various scenarios of incomplete marker's values: a simulation study.
    Vourli G; Touloumi G
    Biom J; 2015 Mar; 57(2):254-70. PubMed ID: 25352223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marginal structural models as a tool for standardization.
    Sato T; Matsuyama Y
    Epidemiology; 2003 Nov; 14(6):680-6. PubMed ID: 14569183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.